Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticlePractical Protocol Tips

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Amanda Abbott and Heather Jacene
Journal of Nuclear Medicine Technology September 2018, 46 (3) 245-246; DOI: https://doi.org/10.2967/jnmt.118.217844
Amanda Abbott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Jacene
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 46 no. 3 245-246
DOI 
https://doi.org/10.2967/jnmt.118.217844
PubMed 
30076242

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online September 6, 2018.

Article Versions

  • previous version (August 3, 2018 - 11:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Practical Considerations for Implementation of177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
    Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa, Stephen A. Graves
    Journal of Nuclear Medicine Technology 2022 50 3

Article usage

Article usage: August 2018 to April 2025

AbstractFullPdf
Aug 20184012
Sep 201862632
Oct 2018261814
Nov 2018352620
Dec 20181658
Jan 201922310
Feb 20193079
Mar 20193826
Apr 201958925
May 20193423
Jun 201941124
Jul 201934146
Aug 201917611
Sep 201934526
Oct 201905636
Nov 201907024
Dec 201903420
Jan 202003416
Feb 202004420
Mar 202003714
Apr 202003012
May 202003716
Jun 202004220
Jul 202003717
Aug 202002915
Sep 202001716
Oct 20200167
Nov 202002910
Dec 202002014
Jan 20210138
Feb 202101920
Mar 202103726
Apr 202101716
May 202102641
Jun 202102237
Jul 202101814
Aug 202102815
Sep 202103019
Oct 202102024
Nov 202101616
Dec 202101912
Jan 2022077
Feb 202201913
Mar 202201520
Apr 202201212
May 202201028
Jun 20220613
Jul 20220148
Aug 202201514
Sep 202202821
Oct 202201611
Nov 202201920
Dec 20220512
Jan 20230125
Feb 20230139
Mar 202301010
Apr 202301915
May 202301410
Jun 2023066
Jul 20230714
Aug 2023068
Sep 2023067
Oct 2023057
Nov 202301514
Dec 202302520
Jan 202401415
Feb 20240129
Mar 2024011110
Apr 202402412
May 202402811
Jun 202402115
Jul 202401720
Aug 202402610
Sep 202401511
Oct 202402110
Nov 20240158
Dec 20240137
Jan 202501020
Feb 202502315
Mar 202502014
Apr 202505537
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 46 (3)
Journal of Nuclear Medicine Technology
Vol. 46, Issue 3
September 1, 2018
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Amanda Abbott, Heather Jacene
Journal of Nuclear Medicine Technology Sep 2018, 46 (3) 245-246; DOI: 10.2967/jnmt.118.217844

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Amanda Abbott, Heather Jacene
Journal of Nuclear Medicine Technology Sep 2018, 46 (3) 245-246; DOI: 10.2967/jnmt.118.217844
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
  • Google Scholar

More in this TOC Section

  • 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy
  • 223Ra-Dichloride Therapy
  • 18F-FDG PET/CT Brain Imaging
Show more Practical Protocol Tips

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire